NCT03872674View on ClinicalTrials.gov

A Trial Comparing High-flow Nasal Oxygen With Standard Management for Conscious Sedation During Endoscopic Retrograde Cholangiopancreatography in Prone Position

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 18, 2019

Study Completion Date

April 18, 2019

Conditions
Patients Undergoing Endoscopic Retrograde Cholangiopancreatography in Prone Position
Interventions
BIOLOGICAL

high-flow humidified oxygen-delivery system (OptiFlow THRIVE)

stand oxygenation arm will receive oxygen at 5 L/min via nasal cannula, while Optiflow THRIVE arm will receive oxygen at 50 L/min via Optiflow THRIVE during the procedure.

Trial Locations (1)

03722

Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03872674 - A Trial Comparing High-flow Nasal Oxygen With Standard Management for Conscious Sedation During Endoscopic Retrograde Cholangiopancreatography in Prone Position | Biotech Hunter | Biotech Hunter